Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000845471 | SCV000987562 | likely benign | not provided | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001087465 | SCV001008070 | likely benign | Long QT syndrome | 2023-04-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345930 | SCV002648711 | likely benign | Cardiovascular phenotype | 2020-09-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003892774 | SCV004715810 | likely benign | AKAP9-related disorder | 2021-10-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |